Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.69997 | 73 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.3944 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.41457 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.27622 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.39528 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.50484 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.46278 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.52312 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.26244 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.4928 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.37388 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.26925 | 69 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.36792 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.40245 | 71 |